What Is Gas6 The Vitamin K Dependent Signaling Protein?

Gas6 is a protein your body makes that depends on vitamin K to work properly. Its full name is growth arrest-specific 6, and it acts as a signaling molecule — a chemical messenger that helps cells communicate. Gas6 is involved in processes like cell survival, blood clotting, inflammation, and the cleanup of dying cells. It is not a vitamin, not a supplement, and not something you consume. It is a protein your body produces, and vitamin K is required to activate it.

What Is Gas6 The Vitamin K Dependent Signaling Protein?

Gas6 is a secreted protein encoded by the GAS6 gene. It belongs to a family of proteins that share a specific structural domain called the Gla domain. That domain requires vitamin K to become functional.

Here is how the vitamin K connection works. For Gas6 to bind calcium and interact with cell membranes, specific glutamate residues in the protein must be converted to gamma-carboxyglutamate (often abbreviated Gla). This conversion is a chemical modification called gamma-carboxylation, and the enzyme that performs it requires vitamin K as a cofactor. Without vitamin K, Gas6 cannot be properly carboxylated, which means it cannot function normally.

This same vitamin K–dependent modification applies to several well-known clotting proteins — factors II, VII, IX, and X, along with proteins C, S, and Z. Gas6 is part of that broader group, though its role extends well beyond clotting.

Gas6 binds to receptors on cell surfaces called TAM receptors — specifically Tyro3, Axl, and Mer. When Gas6 attaches to these receptors, it triggers signaling inside the cell. That signaling can influence whether a cell survives or dies, how immune cells respond to threats, and how the body clears out cells that are no longer needed.

What Does Gas6 Do in the Body?

Gas6 participates in several distinct biological processes. The research on each varies in depth, so it helps to separate what is well established from what remains under investigation.

Cell Survival and Growth

When Gas6 activates the Axl receptor, it can promote cell survival. This means it helps cells resist programmed cell death, a normal process called apoptosis. In healthy tissue, this has a protective role — it helps certain cells stay alive when they might otherwise die prematurely. In cancer, however, this same survival signal can work against the body. Some cancer cells produce more Gas6 or more Axl receptors to avoid dying, which is one reason researchers have studied Gas6 and Axl as potential targets for cancer therapy.

The evidence here is stronger for the basic biology than for clinical applications. Laboratory and animal studies consistently show Gas6–Axl signaling promotes survival. Whether blocking this pathway improves outcomes in human cancer treatment is still being tested in clinical trials. No approved therapy currently targets Gas6 directly.

Clearance of Dying Cells

When cells die naturally, they need to be removed before they break apart and spill their contents, which could trigger inflammation. This removal process is called efferocytosis. Gas6 helps mark dying cells for clearance by binding to a molecule called phosphatidylserine that appears on the surface of cells undergoing apoptosis. Immune cells then recognize this Gas6 tag and engulf the dying cell.

This is one of the better-understood functions of Gas6. Research in animal models has shown that when Gas6 is absent or nonfunctional, the clearance of apoptotic cells is impaired. That impairment can lead to inflammation and, in some models, autoimmune-like responses.

Inflammation and Immune Regulation

Gas6 signaling through TAM receptors plays a role in dampening inflammation. When immune cells detect apoptotic cells through Gas6–TAM signaling, they tend to shift toward an anti-inflammatory response rather than an aggressive attack. This prevents the immune system from reacting to the body’s own dying cells as if they were invaders.

Some studies suggest that disruptions in this system may contribute to chronic inflammatory conditions and autoimmune diseases. The evidence is suggestive but not conclusive. Researchers continue to investigate whether Gas6 levels or TAM receptor activity could serve as biomarkers or treatment targets for conditions like lupus, rheumatoid arthritis, and others.

Blood Clotting and Platelet Function

Gas6 is present in platelets and is released when platelets activate. It appears to contribute to platelet aggregation and clot stability. However, its role in clotting is not as central as that of the classical clotting factors. People with normal clotting factor levels but altered Gas6 activity do not typically have obvious bleeding disorders.

This is an area where biological plausibility outpaces clinical evidence. Gas6 clearly participates in platelet signaling in laboratory studies. Whether modulating Gas6 would meaningfully change bleeding or clotting risk in humans is not established.

How Is Gas6 Related to Vitamin K?

Gas6 cannot perform its signaling function without vitamin K–dependent carboxylation. This is the same biochemical step that activates clotting factors and proteins C and S.

Vitamin K comes in two main dietary forms: vitamin K1 (phylloquinone), found in leafy green vegetables, and vitamin K2 (menaquinones), found in fermented foods and some animal products. The body also recycles vitamin K through a cycle involving the enzyme VKORC1. This recycling allows small amounts of vitamin K to support repeated rounds of carboxylation.

What happens when vitamin K is deficient? The classical consequence is impaired clotting, because clotting factors are also vitamin K–dependent. Gas6 activity would theoretically also be reduced. But because Gas6 is not essential for survival in the way clotting factors are, the clinical effects of reduced Gas6 activity are harder to detect and less well documented.

Warfarin and similar blood-thinning medications work by blocking the vitamin K cycle. This reduces the activity of all vitamin K–dependent proteins, including Gas6. Some researchers have proposed that Gas6 inhibition might contribute to some of warfarin’s effects beyond anticoagulation, but this remains a hypothesis rather than an established mechanism.

Is Gas6 Measured in Blood Tests?

Gas6 is not part of routine blood testing. Your doctor will not order a Gas6 level during a standard checkup, and no clinical guidelines recommend measuring it to diagnose or monitor any disease.

In research settings, scientists can measure Gas6 levels in blood plasma using specialized assays. Studies have looked at whether Gas6 levels correlate with various conditions — cardiovascular disease, kidney disease, cancer, and others. Some research has found associations, but these findings have not translated into clinical tests.

An association in a study does not mean Gas6 causes the disease or that measuring it would help guide treatment. Many proteins show statistical associations with diseases without being useful as clinical tools. Gas6 is currently in that category.

What Is the Evidence for Gas6 as a Treatment Target?

Drug companies have invested in developing drugs that block Gas6–Axl signaling, mainly for cancer. The logic is straightforward: if cancer cells use this pathway to survive, blocking it might make them more vulnerable to treatment or cause them to die on their own.

Several Axl inhibitors have entered early-phase clinical trials. Results so far have been mixed. Some trials showed limited benefit as single agents. Others are testing combinations with chemotherapy or immunotherapy. It is too early to say whether any of these approaches will prove effective in humans.

This is a common pattern in drug development. A pathway looks promising in laboratory studies, but the complexity of human biology means the results do not always carry over. Gas6–Axl is still being actively investigated, and no conclusions about its clinical value can be drawn yet.

What Should You Take Away From All This?

Gas6 is a real, well-characterized protein with important signaling functions. It depends on vitamin K to work. It helps cells survive, assists in clearing dead cells, modulates inflammation, and participates in platelet function.

What it is not: a supplement ingredient, a direct measure of your vitamin K status, or a proven treatment target for any disease. You cannot buy Gas6. You cannot meaningfully change your Gas6 levels through diet beyond maintaining normal vitamin K status.

Eating a diet with adequate vitamin K supports the normal function of all vitamin K–dependent proteins, including Gas6. That is a reasonable takeaway grounded in established nutrition science. Beyond that, the clinical significance of Gas6 in human health is still being worked out.